Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

NCT06756932

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +6 more
Locations
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Md Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia
View all 14 locations
View Trial Details
Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +11 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 62 locations
View Trial Details
Recruiting

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

NCT06417801

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ensino E Terapia de Inovação Clínica Amo - Ética Salvador, Estado de Bahia, Brazil
  • Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • Fundação Antonio Prudente - A.C. Camargo Cancer Center São Paulo, Brazil
  • Instituto D'Or de Pesquisa E Ensino - São Paulo São Paulo, Brazil
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

NCT03424005

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Rocky Mountain Cancer Center - Longmont Longmont, Colorado, United States
View all 53 locations
View Trial Details
Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

Conditions
Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 44 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Hospital of Traditional Chinese Medicine) Lanzhou, Gansu, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Wenzhou Medical University Affiliated Second Hospital Wenzhou, Zhejiang, China
View all 30 locations
View Trial Details
Recruiting

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

NCT06982521

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 231 locations
View Trial Details

Related conditions